rdf-syntax-grammar
mods:
  schema location: http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd
  title info:
    title: Assessing the Medication Abortion Drug Dispensing Practices of Private Sector Chemists through Mystery Client surveys in Nepal
  name:
    role:
      role term: creator
    role:
      role term: Population Services International.
  type of resource: text
  origin info:
    date issued: c2013
    issuance: monographic
  language:
    language term: eng
  physical description:
    form: print
    extent: 19p.
  abstract: SUMMARY: Unplanned pregnancies remain a common problem in Nepal, despite a decline in the total fertility rate from 5.1 births per woman in 1984-1986 to 2.6 births in 2008-2010. Specifically, 27.5% of currently married women of reproductive age (WRA) have an unmet need for family planning.1Furthermore, maternal morbidity and mortality due to unsafe abortions remain high, with estimates that about half of maternal deaths are due to unsafe abortion. While the Department of Health services (DoHS) Annual Report 2010/11 found that 95,306 women received safe abortion services during the 2010/11 fiscal year, unsafe abortions remain a significant problem in Nepal for reasons including lack of knowledge about legalization of abortion and availability of safe abortion services, inadequate access to safe abortion services, high cost of services, reluctance or fear of utilizing the services in time, poor supportive environments, and social stigma. To reduce unsafe abortions and increase access to safe abortion services through medication abortion (MA), PSI/Nepal's Women's Health Program (WHP) has collaborated with the Family Health Division/Ministry of Health and Population (MoHP). PSI/Nepal's program aims to increase awareness of MA as a safe abortion method through various behavior change communication (BCC) activities including a mass media campaign, community-based interpersonal communication (IPC), community-based advocacy meetings, and informal household level meetings. PSI/Nepal is also involved in the social marketing of the first legally registered safe abortion drug in Nepal, Medabon (mifepristone and misoprostol), and is currently distributing Medabon to government authorized health facilities and retail outlets in the country. In February 2013, PSI/Nepal conducted a Mystery Client (MC) survey with 260 chemists to gather information about MA dispensing practices and counseling behavior amongst chemists. Two scenarios were developed to represent different types of pos…
  note: Research Report.
  subject:
    topic: Medication Abortion
  subject:
    topic: Private Sector
  subject:
    topic: Mystery Client
  subject:
    topic: Nepal
  classification: RES00825
  identifier: http://nhrc.gov.np/contact/
  record info:
    record creation date: 181224
    record change date: 20220906184704.0